Equity Equity (Tables)

3 Months Ended

Mar. 31, 2022

Equity [Abstract]

Schedule of Series B Preferred Stock

The below table illustrates changes in the Company’s balance of Series B Preferred Stock for the three months ended March 31, 2022 (in thousands, except share amounts):

	Series B Preferred Stock
	Shares	Amount
Balance at December 31, 2021	100,000	$	92,494
Activity	—	—
Balance at March 31, 2022	100,000	$	92,494

The below table illustrates changes in the Company’s balance of Series B Preferred Stock for the three months ended March 31, 2021 (in thousands, except share amounts):

	Series B Preferred Stock
	Shares	Amount
Balance at December 31, 2020	100,000	$	91,568
Deemed dividends	—	462
Balance at March 31, 2021	100,000	$	92,030

Summary of Restricted Stock Awards by Award Type

The below table summarizes activity of unvested restricted stock awards by award type from January 1, 2022 through March 31, 2022. Unvested RSA awards noted below are included in issued and outstanding common stock as of March 31, 2022, while unvested RSU awards are not included in issued or outstanding common stock as of March 31, 2022.

	RSA			RSU
	Number of Shares	Weighted-Average Grant Date  Fair Value		Number of Shares	Weighted-Average Grant Date  Fair Value
Unvested at January 1, 2022	877,197	$	4.26	4,228,919	$	8.64
Granted	—	—		2,183,670	5.21
Vested	(16,001)	3.14		(1,553,305)	8.18
Forfeited	(667)	5.12		(46,155)	10.07
Unvested at March 31, 2022	860,529	$	4.28	4,813,129	$	7.22

Summary of Stock Options Activity

A summary of stock option activity for the three months ended March 31, 2022 is presented below:

	Number of Shares	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value
Outstanding at January 1, 2022	1,444,845	$	5.18
Granted	—	—
Exercised	(124,334)	1.33
Unvested options forfeited	—	—
Vested options expired	(5,000)	7.24
Outstanding at March 31, 2022	1,315,511	5.53		1.39	696,582
Exercisable at March 31, 2022	1,315,511	$	5.53	1.39	$	696,582